Pressure Sores (Decubitus Ulcers)

Pressure sores, also known as decubitus ulcers or bedsores, are localized areas of tissue necrosis that develop when soft tissue is compressed between a bony prominence and an external surface for a prolonged period. This compression leads to ischemia, cell death, and ultimately ulceration. In veterinary medicine, pressure sores are most commonly observed in recumbent, paralyzed, or heavily sedated patients, particularly over bony prominences such as the greater trochanter, tuber ischii, olecranon, and lateral malleolus. The severity of pressure sores is graded from I to IV based on the depth of tissue involvement, with Grade I being non-blanchable erythema and Grade IV involving full-thickness tissue loss with exposed bone, tendon, or muscle. Pressure sores are a significant clinical concern due to their potential for deep infection, sepsis, and delayed healing, and they require a comprehensive approach to prevention and management.

The primary etiology of pressure sores is unrelieved pressure on soft tissues over bony prominences. This pressure exceeds capillary filling pressure (approximately 32 mmHg), leading to capillary occlusion, ischemia, and subsequent tissue necrosis. Contributing factors include shearing forces, friction, moisture, and maceration. In veterinary patients, common causes include prolonged recumbency due to neurological disease (e.g., intervertebral disc disease, spinal trauma), orthopedic conditions (e.g., fractures, severe osteoarthritis), metabolic diseases (e.g., diabetes mellitus, Cushing's disease), and postoperative states with prolonged anesthesia or immobility. Additionally, poor nursing care, inadequate padding, and improper positioning exacerbate the risk. Malnutrition, dehydration, and anemia further compromise tissue viability and healing. In some cases, iatrogenic causes such as tight bandages, casts, or splints can also lead to pressure necrosis.

Pressure sores are most commonly reported in dogs, particularly large and giant breeds, due to their greater body weight and larger bony prominences. Cats are less frequently affected but can develop pressure sores, especially when recumbent. There is no strong breed predisposition, but breeds with thin skin and minimal subcutaneous fat, such as Greyhounds and Doberman Pinschers, may be at higher risk. Age is a significant factor, with older animals being more susceptible due to decreased mobility, thinner skin, and comorbidities. Sex distribution is generally equal. Working dogs, such as those used for search and rescue or military purposes, may be at increased risk due to prolonged periods of recumbency during transport or recovery from injury. The incidence of pressure sores in veterinary hospitals is not well-documented, but it is estimated that up to 25% of recumbent patients may develop some degree of pressure injury. In human medicine, the incidence is higher in intensive care units, and similar trends are likely in veterinary critical care settings.

The pathophysiology of pressure sores involves a complex interplay of mechanical forces, ischemia, reperfusion injury, and cellular dysfunction. Prolonged pressure on soft tissue leads to occlusion of capillaries and venules, resulting in ischemia and hypoxia. This triggers a cascade of cellular events, including ATP depletion, accumulation of reactive oxygen species, and activation of inflammatory mediators. If pressure is relieved, reperfusion can cause additional injury through the generation of free radicals and activation of neutrophils. The tissue damage progresses from the deepest layers (muscle and bone) outward to the skin, which is why superficial examination may underestimate the severity. Shearing forces cause stretching and tearing of blood vessels, leading to thrombosis and further ischemia. Friction and moisture macerate the skin, increasing susceptibility to breakdown. Over time, the affected tissue undergoes coagulative necrosis, and secondary bacterial infection can lead to cellulitis, abscessation, and osteomyelitis. Systemic effects include sepsis, which can be life-threatening.

Intrinsic predisposing factors include conformational characteristics such as prominent bony prominences, thin skin, and minimal subcutaneous fat. Genetic factors may influence skin thickness and collagen quality. Metabolic diseases such as diabetes mellitus, hyperadrenocorticism, and hypothyroidism impair wound healing and increase susceptibility to infection. Age-related changes, including decreased dermal thickness and reduced vascularity, contribute to risk. Obesity can increase pressure on bony prominences, while cachexia reduces the protective cushioning of fat and muscle. Extrinsic factors include prolonged recumbency, inadequate padding, improper positioning, and poor nursing care. Moisture from urine, feces, or wound exudate macerates the skin. Friction from dragging limbs or rubbing against bedding causes abrasions. Prior surgeries or trauma may create areas of devitalized tissue. Excessive activity in a recumbent patient can cause shearing forces. Nutritional deficiencies, particularly protein, vitamin C, and zinc, impair tissue repair.

Clinical signs of pressure sores vary with the grade of the lesion. Grade I presents as non-blanchable erythema over a bony prominence, with intact skin. The area may be warm, firm, or painful. Grade II involves partial-thickness skin loss, presenting as a superficial ulcer or blister. Grade III is characterized by full-thickness skin loss with damage to subcutaneous tissue, but not through the underlying fascia. The ulcer may appear as a deep crater with undermining of the skin edges. Grade IV involves full-thickness skin loss with extensive destruction, tissue necrosis, or damage to muscle, bone, or supporting structures. In advanced stages, there may be a foul odor, purulent discharge, and visible bone or tendon. Systemic signs include fever, lethargy, and anorexia if infection is present. Pain may be significant, especially during dressing changes or movement. In recumbent patients, pressure sores are often found over the greater trochanter, tuber ischii, olecranon, and lateral malleolus. In some cases, the sore may be covered by a scab or eschar, masking the underlying severity.

Differential diagnoses for pressure sores include other causes of skin ulceration and necrosis. 1. Thermal burns: History of heat or chemical exposure, with characteristic lesion distribution and depth. 2. Chemical burns: Exposure to caustic substances, with lesions often on the paws or ventral body. 3. Traumatic wounds: Abrasions, lacerations, or degloving injuries, with a history of trauma and irregular wound edges. 4. Neoplasia: Squamous cell carcinoma, mast cell tumor, or other skin tumors can ulcerate; cytology and biopsy are diagnostic. 5. Deep pyoderma: Bacterial skin infection, often with furunculosis and draining tracts; responds to antibiotics. 6. Vasculitis: Immune-mediated inflammation of blood vessels, leading to ischemic necrosis; skin biopsy shows leukocytoclastic vasculitis. 7. Frostbite: Cold exposure, with lesions on extremities; history and clinical appearance. 8. Injection site reactions: History of recent injection, with necrosis at the injection site. 9. Eosinophilic granuloma complex: In cats, ulcerative lesions on the skin, often on the lips or chin; biopsy shows eosinophilic infiltration. 10. Calcinosis cutis: Associated with hyperadrenocorticism, with firm, gritty plaques that ulcerate; histopathology shows calcium deposition.

The diagnostic algorithm for pressure sores begins with a thorough physical examination, including assessment of the lesion's location, size, depth, and presence of necrosis or infection. The patient's history, including recumbency duration, underlying diseases, and nursing care, is crucial. A pressure sore is primarily a clinical diagnosis, but diagnostic imaging and laboratory tests are essential to assess the extent of tissue damage and rule out complications. 1. Clinical assessment: Grade the sore using the National Pressure Injury Advisory Panel (NPIAP) staging system. 2. Wound culture: If infection is suspected, obtain a deep tissue culture for aerobic and anaerobic bacteria. 3. Radiography: To evaluate for underlying osteomyelitis, especially in Grade IV sores. 4. Ultrasonography: Can assess soft tissue involvement and fluid pockets. 5. Computed tomography (CT) or magnetic resonance imaging (MRI): In complex cases, to delineate the extent of deep tissue necrosis and plan surgical debridement. 6. Laboratory tests: Complete blood count, serum biochemistry, and urinalysis to identify systemic infection, metabolic disorders, and nutritional status. 7. Biopsy: If neoplasia or vasculitis is suspected, a biopsy of the wound edge is indicated. 8. Nutritional assessment: Evaluate serum albumin, prealbumin, and total protein to guide nutritional support.

Laboratory findings in pressure sores are non-specific but can reflect underlying disease and complications. Complete blood count may show leukocytosis with a left shift if there is secondary bacterial infection. Anemia may be present due to chronic disease or blood loss. Serum biochemistry may reveal hypoalbuminemia, indicating malnutrition or protein-losing enteropathy. Elevated liver enzymes may be seen in patients with hyperadrenocorticism. Blood glucose levels should be checked to rule out diabetes mellitus. Urinalysis may show evidence of urinary tract infection, which is common in recumbent patients. Coagulation panel (PT, aPTT, platelet count) is important if surgical debridement is planned, as some patients may have coagulopathies due to liver disease or sepsis. Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) may be elevated, indicating systemic inflammation. Synovial fluid analysis is not typically performed unless there is joint involvement. Wound cultures should be obtained from deep tissue, not superficial swabs, to identify causative organisms and guide antibiotic therapy.

Imaging plays a crucial role in assessing the extent of pressure sores, particularly in deep lesions. Radiography is the first-line modality to evaluate for underlying osteomyelitis. Findings may include periosteal reaction, osteolysis, and sequestrum formation. In early osteomyelitis, radiographs may be normal, so advanced imaging is often needed. Ultrasonography can assess soft tissue involvement, detect fluid pockets or abscesses, and guide aspiration for culture. Computed tomography (CT) provides detailed three-dimensional information about bone and soft tissue, and is excellent for surgical planning. CT findings include soft tissue swelling, gas within the tissues, and bone destruction. Magnetic resonance imaging (MRI) offers superior soft tissue contrast and is useful for evaluating muscle necrosis, deep abscesses, and sinus tracts. MRI can differentiate between viable and non-viable tissue, aiding in surgical debridement. In some cases, fluoroscopy or angiography may be used to assess vascularity. Imaging should be performed before surgical intervention to ensure complete debridement and to plan reconstruction.

Cytology and histopathology are important for diagnosing pressure sores and ruling out other conditions. Fine-needle aspiration of the wound bed or surrounding tissue can be performed to evaluate for infection or neoplasia. Cytology may show neutrophils, macrophages, and bacteria if infection is present. If a mass is suspected, aspiration of the mass can help differentiate between inflammatory and neoplastic processes. Histopathology of a biopsy from the wound edge is essential if neoplasia or vasculitis is suspected. In pressure sores, histopathology typically shows coagulative necrosis of the skin and subcutaneous tissue, with thrombosis of blood vessels and inflammatory infiltrate. Special stains, such as Gram stain, can identify bacteria. If osteomyelitis is present, bone biopsy may be performed. Histopathology can also assess the viability of tissue margins during surgical debridement, ensuring that all necrotic tissue is removed. In cases of chronic pressure sores, squamous cell carcinoma can develop in the ulcer bed (Marjolin's ulcer), so biopsy of chronic wounds is recommended.

Treatment of pressure sores involves a multimodal approach, including wound care, surgical debridement, infection control, nutritional support, and prevention of further pressure. The first step is to relieve pressure on the affected area by repositioning the patient every 2-4 hours, using padded bedding (e.g., egg-crate foam, water beds, or specialized pressure-relief mattresses), and using donut-shaped cushions to offload bony prominences. Wound care includes cleaning with sterile saline or a dilute chlorhexidine solution, and debriding necrotic tissue. Debridement can be surgical, enzymatic, or autolytic. Surgical debridement is the most effective for deep sores, and may be performed sharply or with a scalpel, scissors, or curette. The goal is to remove all non-viable tissue, including necrotic bone, until healthy bleeding tissue is reached. After debridement, the wound can be managed with wet-to-dry dressings, hydrocolloid dressings, or negative-pressure wound therapy (NPWT) to promote granulation. Antibiotic therapy is indicated if there is evidence of infection, based on culture and sensitivity. Systemic antibiotics such as amoxicillin-clavulanate (13.75 mg/kg PO q12h) or cefazolin (22 mg/kg IV q8h) may be used. In severe cases, surgical reconstruction may be necessary, including skin grafts, flaps, or muscle flaps to cover the defect. Nutritional support is critical, with high-protein diets and supplements such as L-arginine, zinc, and vitamin C to enhance wound healing. Pain management is essential, using opioids (e.g., tramadol 2-5 mg/kg PO q8-12h) or NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h) as appropriate.

The prognosis for pressure sores depends on the severity, underlying cause, and response to treatment. Grade I and II sores have a good prognosis with prompt intervention and pressure relief, often healing within 1-2 weeks. Grade III sores may take several weeks to months to heal, especially if there is significant tissue loss. Grade IV sores have a guarded prognosis, particularly if there is osteomyelitis or systemic infection. Complications such as sepsis, osteomyelitis, and delayed healing can worsen the prognosis. The underlying disease process is a major determinant; if the patient remains recumbent, the risk of recurrence is high. With aggressive management, including surgical debridement, appropriate wound care, and nutritional support, many pressure sores can be successfully treated. However, in severe cases, amputation of the affected limb may be necessary if the sore is non-healing and causes severe pain or infection. Overall, the prognosis is better in patients that can be mobilized and have good nutritional status.

Follow-up care for pressure sores is essential to monitor healing and prevent recurrence. Initially, wounds should be assessed daily, with dressing changes as needed. After surgical debridement, the wound should be re-evaluated every 2-3 days to assess for healthy granulation tissue and signs of infection. Sutures or staples, if used for reconstruction, are typically removed in 10-14 days. Serial photographs and wound measurements can track progress. Radiographs should be repeated every 2-4 weeks if osteomyelitis is present, to monitor bone healing. The patient's nutritional status should be monitored with regular serum albumin and total protein measurements. Physical therapy, including passive range of motion exercises and massage, can help maintain muscle mass and joint mobility. The patient's environment should be optimized to prevent pressure, with continued use of padded bedding and regular repositioning. Long-term follow-up is necessary to ensure the wound remains closed and to detect any signs of recurrence or malignant transformation. Owners should be educated on proper nursing care and signs of complications.

Clinical pearls: 1. Prevention is the best treatment; implement a turning schedule and use pressure-relief bedding from the start. 2. Always assess the depth of the sore; superficial appearance can be deceiving. 3. Use a sterile cotton-tipped applicator to probe the wound and determine the extent of undermining. 4. Culture deep tissue, not superficial swabs, to guide antibiotic therapy. 5. Surgical debridement should be aggressive, removing all necrotic tissue until healthy bleeding tissue is seen. 6. Consider negative-pressure wound therapy for large, exudative wounds. 7. Nutritional support is crucial; consider enteral feeding if the patient is anorexic. 8. In chronic wounds, biopsy to rule out neoplasia. Pitfalls: 1. Failing to relieve pressure, which leads to continued tissue damage. 2. Using wet-to-dry dressings on healthy granulation tissue, which can cause trauma. 3. Inadequate debridement, leaving necrotic tissue that promotes infection. 4. Using antibiotics without culture, leading to resistance. 5. Neglecting pain management, which can impair healing. 6. Allowing the wound to become contaminated with feces or urine. 7. Delaying surgical reconstruction, which can lead to excessive scar formation. 8. Ignoring underlying systemic diseases that impair healing.

Perioperative pharmacological protocols for pressure sore management include: 1. Prophylactic antibiotics: Cefazolin (22 mg/kg IV) administered 30 minutes before surgical debridement, and repeated every 90 minutes during surgery. Postoperatively, continue with amoxicillin-clavulanate (13.75 mg/kg PO q12h) for 7-10 days if infection is present. 2. Analgesics: For moderate to severe pain, opioids such as morphine (0.5-1 mg/kg IM or IV q4-6h) or fentanyl CRI (2-5 mcg/kg/hr) are used. For mild to moderate pain, NSAIDs such as carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) can be used, but caution is advised in patients with renal or hepatic disease. Local anesthetic blocks, such as lidocaine (2 mg/kg) or bupivacaine (1 mg/kg), can be infiltrated around the wound for postoperative analgesia. 3. Muscle relaxants: If the patient has muscle spasms, diazepam (0.2-0.5 mg/kg IV or PO q8h) or methocarbamol (15-20 mg/kg PO q8h) may be used. 4. Chondroprotectants: Not directly relevant, but if there is joint involvement, glucosamine and chondroitin sulfate can be used. 5. Wound healing supplements: Zinc (1 mg/kg PO q24h), vitamin C (10-20 mg/kg PO q24h), and L-arginine (500 mg PO q12h) may promote healing. 6. Topical agents: Silver sulfadiazine cream (1%) applied to the wound q24h, or medical-grade honey, can be used to reduce bacterial load. 7. Nutritional support: If hypoalbuminemia is present, consider enteral or parenteral nutrition. All dosages should be adjusted based on renal and hepatic function.

Evidence-based literature on pressure sores in veterinary medicine is limited, but several studies provide guidance. A retrospective study by Swaim et al. (2003) evaluated the use of negative-pressure wound therapy in dogs with chronic wounds, including pressure sores, and found improved granulation tissue formation and reduced wound size. Another study by Bohling et al. (2004) compared different dressing materials for open wound management, including pressure sores, and found that hydrocolloid dressings were effective in maintaining a moist environment and promoting healing. A consensus statement from the World Small Animal Veterinary Association (WSAVA) on wound management emphasizes the importance of pressure relief and nutritional support. In human medicine, the National Pressure Injury Advisory Panel (NPIAP) guidelines provide evidence-based recommendations for staging and management, which are often extrapolated to veterinary patients. A study by Ward et al. (2011) in dogs with intervertebral disc disease found that the incidence of pressure sores was significantly reduced with the use of specialized padded bedding and a turning schedule. Overall, the evidence supports early intervention, aggressive debridement, and multimodal management to improve outcomes.